德英生物科技
News

Events

2023.05.31

Events

Dr. Kou-Wha, Kuo of G&E Herbal Biotechnology Invited by Tao Sheng-Yang Anti-Cancer Foundation
to Host a Public Health Lecture on Cancer Prevention

Date: May 30

Location: Taichung, Taiwan

Organizer: Tao Sheng-Yang Anti-Cancer Foundation

Lecture Topic:

【Research and Development of the Novel Global Ingredient SR-100 in Cancer Treatment】

About D&E Biotechnology:

G&E Herbal Biotechnology is a publicly listed professional company specializing in plant-based new drug development. It operates a PIC/S GMP-certified pharmaceutical plant, active pharmaceutical ingredient (API) plant, food and supplement plants, and a plant-drug activity and mechanism research center approved by the Chinese Management Science Association. The company develops high-quality plant-based drugs under international pharmaceutical standards, aiming to treat clinically challenging cancers and liver, gallbladder, and kidney diseases.

Global Patents of SR-100:

  • Dr. Kuo developed the globally exclusive patented ingredient SR-100.
  • The product line includes health and wellness products such as "SR-100 SolaGen Capsule" and "SR-100 Topical Gel".
  • SR-100 has received invention patents in dozens of countries, including the USA and EU.
  • Phase III clinical trial (code SR-T100) has been completed.
  • All products are strictly controlled, free of preservatives and artificial additives, and use natural plant extracts that are safe and gentle.

Product Information:

SR-100 SolaGen Capsule

SR-100 Topical Gel

SR-100 Botanical Skincare GliteR Series
Cancer Prevention Lecture Photo 1
Cancer Prevention Lecture Photo 2